Pfizer Inc
CIK
78003
Location
New York, NY
Portfolio Value
Small
$174,619,180
Diversification
Moderately concentrated
Filing Date
Global Rank
#4,879
/ 8,700
▲ 374
Top Industry
Biotechnology
100.0%
Period ended 2 months ago
Filed Aug 13, 2026 · 31d
7 quarters · since Dec 2024
Portfolio Concentration
16 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
26.2%
+2.3 pts
Top 5
78.8%
−0.8 pts
Top 10
95.8%
−0.6 pts
HHI
1,528
Moderately concentrated+7
Portfolio Trend
7 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $174,619,180 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | 101,618 | $652,387 | |
| No positions match the current search. | ||||
16 tracked positions ·
$174,619,180 total
· filing declares
20 positions · $170,365,906
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
Held | 22,032,040 | $45,826,643 | 26.24% | |
| CELC |
Celcuity Inc.
Healthcare
|
Held | 295,652 | $30,931,112 | 17.71% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Held | 3,457,815 | $28,734,442 | 16.46% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Held | 7,032,770 | $21,168,637 | 12.12% | |
| WVE |
Wave Life Sciences, Inc.
Healthcare
|
Held | 1,875,000 | $10,893,750 | 6.24% | |
| CRBU |
Caribou Biosciences, Inc.
Healthcare
|
Held | 4,690,431 | $8,255,158 | 4.73% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 505,645 | $7,523,997 | 4.31% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
Held | 2,362,348 | $5,220,789 | 2.99% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Held | 953,834 | $4,626,094 | 2.65% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 372,904 | $4,038,550 | 2.31% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Reduced | 538,841 | $3,179,161 | 1.82% | |
| CRDF |
Cardiff Oncology, Inc.
Healthcare
|
Held | 2,411,575 | $3,135,047 | 1.80% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
Held | 75,000 | $973,500 | 0.56% | |
| NXTC |
NextCure, Inc.
Healthcare
|
Reduced | 44,347 | $70,954 | 0.04% | |
| DNA |
Ginkgo Bioworks Holdings, Inc.
Healthcare
|
Held | 2,928 | $29,015 | 0.02% | |
| SENS |
Senseonics Holdings, Inc.
Healthcare
|
Held | 2,171 | $12,331 | 0.01% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.